Home Neuronal Signaling Histamine Receptor inhibitor Levodropropizine

research use only

Levodropropizine Histamine Receptor inhibitor

Cat.No.S4131

Levodropropizine((S)-(-)-Dropropizine,DF-526) possess anti-allergic and inhibits histamine receptor, this compound reduces cough by interfering with stimulus activation of peripheral endings of sensory nerves and by modulation of neuropeptides involved in the cough reflex.
Levodropropizine Histamine Receptor inhibitor Chemical Structure

Chemical Structure

Molecular Weight: 236.31

Jump to Mechanism of Action Solubility Chemical Information, Storage & Stability Specificity

Quality Control

Batch: S413101 DMSO]47 mg/mL]false]Ethanol]47 mg/mL]false]Water]15 mg/mL]false Purity: 99.98%
99.98

Chemical Information, Storage & Stability

Molecular Weight 236.31 Formula

C13H20N2O2

 Storage (From the date of receipt)
CAS No. 99291-25-5 Download SDF Storage of Stock Solutions

Synonyms (S)-(-)-Dropropizine,DF-526 Smiles C1CN(CCN1CC(CO)O)C2=CC=CC=C2

Solubility

In vitro
Batch:

DMSO : 47 mg/mL (198.89 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Ethanol : 47 mg/mL

Water : 15 mg/mL

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Mechanism of Action

Features
Demonstrates a better tolerability index than the Racemate.
Targets/IC50/Ki
Histamine receptor [1]
In vitro

Levodropropizine has affinity for H1-histaminic and alpha-adrenergic receptors. [1]
In vivo

Levodropropizine has weaker central sedative effects than the racemate and it does not induce physical dependence in rats. [1] This compound (15 mg/kg, i.v.) reduces both the duration of apnoea and the response of the C-fibre to phenylbiguanide. The LVDP-induced inhibition of the C-fibre response to PBG is on average 50% in pulmonary and 25% in non-pulmonary fibres. [2] It is shown to have good antitussive activity in anaesthetized guinea-pigs and rabbits. This chemical (i.v.) is 1/10 to 1/20 as active as codeine and comparable to dropropizine on mechanically and electrically induced coughing in rabbits and guinea-pigs. It (orally) is comparable with those of both dropropizine and codeine against coughing induced by irritant aerosols. [3] This compound (40 μg/50 μL i.c.v.) does not prevent electrically-induced cough, while Codeine (5 μg/50 μl i.c.v.) markedly prevents coughing in guinea-pigs. It has a peripheral site of action which is related to sensory neuropeptides. [4] This chemical (10 mg/kg, 50 mg/kg and 200 mg/kg) reduces in a dose-dependent manner the extravasation of Evans blue dye evoked by capsaicin in the rat trachea. It (200 mg/kg) inhibits also substance P-evoked extravasation, whereas it does not affect the extravasation evoked by platelet activating factor. [5]
References
  • [4] https://pubmed.ncbi.nlm.nih.gov/1611233/
  • [5] https://pubmed.ncbi.nlm.nih.gov/7504629/

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.

Signaling Pathway Map